Watch to learn more about the ambitious program that brings together large multidisciplinary teams to attack acute myeloid leukemia and myelodysplastic syndrome; chronic lymphocytic leukemia; melanoma; lung cancer; prostate cancer; and triple-negative breast and high-grade serous ovarian cancers.

The Time is Now: Moon Shots Program

With our unparalleled resources and capabilities, MD Anderson is uniquely positioned to accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. What’s learned from the six initial cancer “moon shots” will ultimately lead to cures for all types of the disease. The time is now. Together, we will end cancer.


  • BREAST CANCER

    Katrina Barlow

    Nearly half a million women in the U.S. are affected by breast and ovarian cancer each year. Many will be diagnosed with aggressive forms of these diseases. Triple-negative breast and high-grade serous ovarian cancers share similar genetic causes, and MD Anderson is poised to make significant progress in treatment and prevention of them. Learn more…

  • Leukemia AML

    Kenneth Woo

    Myelodysplastic syndromes (MDS) are a group of malignancies affecting blood cells, and about half of MDS patients go on to develop acute myeloid leukemia (AML), the most common form of leukemia in adults. The incidence of MDS is expected to rise as the population ages and the AML survival rate is less than 30%. The time is now to find more effective therapies for both. Read more…

  • Leukemia CLL

    Vittorio Alliata di Montereale

    Chronic lymphocytic leukemia is the most common type of leukemia in the U.S. and Europe, mostly affecting people over age 55. The past 10-15 years have seen dramatic advances in treatment outcomes for thousands of CLL patients, as new drugs have been developed that target these cancer cells with fewer side effects. Read more…

  • Lung Cancer

    Fe Crawford

    Lung cancer has the most far-reaching impact on our population as it’s the leading cause of cancer death. MD Anderson’s battle against lung cancer is fought on three fronts: prevention, early detection and treatment of advanced disease. Several initiatives are underway. Read more…

  • Melanoma

    Sandy Pierce

    The most aggressive form of skin cancer, annual incidence of melanoma in the U.S. has increased more than 600% since 1950. MD Anderson’s Melanoma Moon Shot integrates efforts in prevention, research and clinical care across the continuum of the disease to reduce trends and save lives. Read more…

  • Prostate Cancer

    Jon Thompson

    Prostate cancer is one of the most common forms of cancer and the second leading cause of death among American men. It’s estimated that more than 238,500 new cases will be diagnosed this year. MD Anderson’s Prostate Cancer Moon Shot is focusing on three areas to reduce mortality. Read more…

Stories of Hope

Leukemia MDS

Jerry Reidy
MDS Survivor

Ovarian Cancer

Betty White
Ovarian Cancer Survivor

Breast Cancer

Katrina Barlow
Breast Cancer Survivor

Lung Cancer

Reba Kennedy
Lung Cancer Survivor